Valuation: Norda ASA

Market Cap 51Cr 5.45Cr 4.75Cr 4.49Cr 4.08Cr 7.62Cr 521.83Cr 7.66Cr 53Cr 21Cr 265.2Cr 20Cr 20Cr 848.97Cr P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 26Cr 2.81Cr 2.44Cr 2.31Cr 2.1Cr 3.93Cr 268.82Cr 3.95Cr 28Cr 11Cr 136.61Cr 11Cr 10Cr 437.33Cr EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 4.72Cr
+1.23%+1.87%-0.15%+9.57% 4.59TCr
+0.23%+4.72%+44.32%+27.27% 4.42TCr
+0.52%-3.15%+349.53%+520.09% 4.2TCr
+1.55%+3.41%+6.40%+76.45% 3.96TCr
+1.75%-0.28%+12.42%+41.11% 3.11TCr
-0.20%+5.49%+23.57%+119.72% 1.72TCr
-3.49%-8.49% - - 1.63TCr
+2.92%+8.40%+22.46%+38.87% 1.5TCr
-2.45%+2.41%-3.16%-35.16% 1.34TCr
Average +0.54%+0.77%+56.93%+99.74% 2.94TCr
Weighted average by Cap. +0.59%+0.33%+72.35%+120.61%

Financials

2023 2024
Net sales 8.69Cr 92.29L 80.39L 76.08L 69.12L 1.29Cr 88Cr 1.3Cr 9.06Cr 3.5Cr 45Cr 3.47Cr 3.39Cr 143.8Cr 37Cr 3.95Cr 3.44Cr 3.25Cr 2.96Cr 5.52Cr 378.13Cr 5.55Cr 39Cr 15Cr 192.17Cr 15Cr 15Cr 615.18Cr
Net income 3.12Cr 33.1L 28.83L 27.28L 24.79L 46.31L 32Cr 46.54L 3.25Cr 1.26Cr 16Cr 1.24Cr 1.22Cr 52Cr 13Cr 1.34Cr 1.16Cr 1.1Cr 1Cr 1.87Cr 128.07Cr 1.88Cr 13Cr 5.08Cr 65Cr 5.02Cr 4.91Cr 208.36Cr
Net Debt -31Cr -3.3Cr -2.88Cr -2.72Cr -2.48Cr -4.62Cr -316.5Cr -4.65Cr -32Cr -13Cr -160.85Cr -12Cr -12Cr -514.91Cr -25Cr -2.64Cr -2.3Cr -2.18Cr -1.98Cr -3.7Cr -253.02Cr -3.71Cr -26Cr -10Cr -128.59Cr -9.92Cr -9.7Cr -411.64Cr
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!